Search Results 51-60 of 17328 for egfr

  1. A Global Study to Assess the Effects of MEDI4736, Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer - Mayo Clinic

    Patients with known EGFR (Epidermal growth factor receptor) tyrosine kinase (TK) activating mutations and anaplastic lymphoma kinase (ALK) rearrangements ...

  2. End-Stage Renal Disease Clinical Trials - Mayo Clinic Research

    ... (eGFR) <30, including those on hemodialysis. DialySafe Device LED Light Assessment for Transillumination Jacksonville, FL. The purpose of this research is to ...

  3. Pemetrexed (intravenous route) - Side effects & uses - Mayo Clinic

    ... EGFR or ALK gene. This medicine is also used in combination with cisplatin as first treatment for non-squamous NSCLC that has spread (locally advanced or ...

  4. Atezolizumab and hyaluronidase-tqjs (subcutaneous route) - Side effects & uses - Mayo Clinic

    ... EGFR or ALK gene. It is also used to treat metastatic non-small cell lung cancer with or without an EGFR or ALK gene in patients who have tried treatment for ...

  5. A Study of Vascular Dysfunction in Polycystic Kidney Disease (PKD) - Mayo Clinic

    ... (eGFR > 60 mL/min/m2, BP<130/90 mmHg), and these correlate with defects in isolated endothelial cells. Participation eligibility. Participant eligibility ...

  6. A Study of Fresolimumab in Patients with Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS) - Mayo Clinic

    To evaluate fresolimumab dose-dependent reduction in proteinuria; To compare the change in renal function (estimated glomerular filtration rate [eGFR]) in ...

  7. Gefitinib (oral route) - Side effects & dosage - Mayo Clinic

    ... (EGFR) genes, and did not receive cancer medicines in the past. Your doctor will perform a test before you take this medicine. Gefitinib belongs to the group ...

  8. A Study of Rociletinib (CO-1686) for Patients with a Mutant form of Non-Small Cell Lung Cancer. - Mayo Clinic

    To provide access to rociletinib for patients with advanced or metastatic EGFR-mutant NSCLC who have been treated previously with EGFR directed therapy and have ...

  9. Evaluation Of Efficacy Of Povetacicept In Adults With Immunoglobulin A Nephropathy (IgAN) - Mayo Clinic

    * Estimated glomerular filtration rate (eGFR) ≥ 30 mL/min/1.73m\^2 * Stable angiotensin converting enzyme inhibitor (ACEi) or angiotensin II receptor ...

  10. Study Of DF9001 In Patients With Advanced Solid Tumors - Mayo Clinic

    The first phase will be a dose escalation phase, enrolling patients with various types of solid tumors that express epidermal growth factor receptor (EGFR).